Viking Global Opportunities Illiquid Investments Sub-Master LP, 10% Owner at 4D Molecular Therapeutics, Inc. (FDMT), sold 540,000 shares at $19.53 ($10.5M) on 2024-01-04, disclosed to the SEC on 2024-01-05.
Open-market sale of $10.5M FDMT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AMLX | SELL | 2022-09-09 | $83.4M | — | Filing → |
| AMLX | BUY | 2022-01-13 | $43.7M | — | Filing → |
| RLYB | BUY | 2021-08-02 | $10.5M | — | Filing → |